About this episode

This episode features Michael Anderson discussing his lived experience with anal cancer, including diagnosis, treatment, and the importance of support networks.

Trigger Warning: this episode talks about cancer, HPV, anal cancer, cancer treatment, side effects, sec and intimacy, clinical trials and stigma. Supported by an unrestricted grant from Incyte Biosciences. Incyte had no involvement in the development, content, or editorial review of the activities associated with this initiative. Description: In this educational episode, Naman Julka-Anderson and Jo McNamara sit down with Michael Anderson. This episode is a deep dive into Michael’s diagnosis, treatment, side effects, clinical trials and Bottomline charity he founded. Michael worked in policy and research for many years and was was diagnosed with anal cancer in 2020. He set up the Bottom Line support group for people living with anal cancer in 2021 which became a charity in 2024. He worked as a patient expert on the National Cancer Plan in 2025 and speaks regularly at conferences, seminars and training events. CPD Reflection Points: Consider how this episode has influenced your understanding of the role that sexual orientation and identity can play in a patient’s cancer journey, and how might this shape the way you deliver more inclusive, person-centred care in the future? Reflect…

Topics covered

• anal cancer
• HPV
• cancer treatment
• clinical trials
• sexual orientation
• support networks
• intimacy

Sponsors

Incyte Biosciences

Explore listener stats, chart rankings, contacts and more on the Rad Chat podcast page.